Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends Takeda’s cancer drug Mepact

September 7, 2011
Sales and Marketing Mepact, NICE, Takeda

NICE has reversed its stance on Mepact and recommended the bone cancer drug after re-examining discounts and a new patient …

News
EMA

EMA should compare ‘like-for-like’ when assessing new drugs

September 7, 2011
Research and Development EMA, clnical trials, research and development news

The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …

News

Sanofi’s Multaq in the dock

September 7, 2011
Sales and Marketing Multaq, Sanofi

The EMA will later this month decide whether Sanofi’s Multaq can remain on the market after reports emerged of serious …

News

AZ’s Nexium faces generic competition in the UK

September 6, 2011
Nexium, Ranbaxy, generics

Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …

News

Lilly considering a stake in Turkish drugmaker

September 6, 2011
Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

News

New API production process ‘could transform pharma’

September 6, 2011
Manufacturing and Production pharma manufacturing news, pharma production

UK researchers have started work on a new project to examine a new production method that they claim could “significantly …

News
Roche

Roche and Evotec to develop Alzheimer’s drug

September 6, 2011
Alzheimer's disease, Evotec, Roche

Roche and Evotec are to collaborate on the development and commercialisation of Evotec’s MAO-B inhibitor in patients with Alzheimer’s disease. …

News

Health reforms face renewed opposition

September 6, 2011
Sales and Marketing NHS reforms

The government’s health reforms in England are coming under attack once again as the legislation returns to Parliament. After the …

News

CSL vaccine probe likely to rule out manufacturing errors

September 6, 2011
Manufacturing and Production CSL Biotherapies, flu, pharma manufacturing news, vaccines

CSL Biotherapies has said that manufacturing errors were likely not to blame for febrile seizures in children who received its …

News

Pharma manufacturing news in brief

September 6, 2011
Manufacturing and Production pharma manufacturing news

USP expands operations in India, DSM gets green light for Chinese anti-infective joint venture, plus there are updates from CMC …

News
Novartis Afinitor

Afinitor expands European licence

September 5, 2011
Sales and Marketing Afinitor, Novartis, Pancreatic cancer

Novartis’ Afinitor has made further strides in the EU with an approval for use in patients with advanced pancreatic neuroendocrine …

News

NICE rejects three bowel cancer drugs

September 5, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

NICE says three treatments – Roche’s Avastin, Merck KgAa’s Erbitux and Amgen’s Vectibix – are all not cost effective in …

News
Boehringer-Lilly's Trajenta

Boehringer-Lilly won’t launch Trajenta in Germany

September 5, 2011
Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts

Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …

News
AstraZeneca's Crestor (rosuvastatin)

Crestor fails head-to-head test against Lipitor

September 2, 2011
Sales and Marketing Crestor, Lipitor

AstraZeneca’s cholesterol drug Crestor has failed to show it can stop artery disease better than Pfizer’s Lipitor. The new study …

News

Philippines pricing controls: Pfizer ‘considered taking drugs off the market’

September 2, 2011
Sales and Marketing Drug pricing, Philippines, price cuts

Pfizer considered withdrawing some of its products from the Philippines rather than face planned pricing controls, according to a US …

News

Zonegran study could pave way for paediatric licence

September 2, 2011
Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news

Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …

News

Robert Yates appointed president of Millipore

September 2, 2011
Sales and Marketing appointment, sales and marketing

Merck KGaA has appointed diagnostics expert Robert Yates to the newly-created role of president at Millipore, the company it acquired …

Appointment
smartphone

Digital Pharma: Mobile marketing

September 1, 2011
Medical Communications Digital Pharma blog, iphone, mobile, smart devices

“This, is not a phone,” said Mark Blayney Stuart holding up his BlackBerry. “It’s a very powerful computer that happens …

Feature
Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011
Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …

News

Stem cell trial for stroke is safe

September 1, 2011
Research and Development ReNeuron, Stem cells, stroke

A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026